CKD-387
- Generic Name
- CKD-387
Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-387 in Healthy Volunteers Under Fed Conditions
Phase 1
Completed
- Conditions
- Endocrine, Nutritional and Metabolic Diseases
- Interventions
- Drug: D484
- First Posted Date
- 2024-05-03
- Last Posted Date
- 2024-05-03
- Lead Sponsor
- Chong Kun Dang Pharmaceutical
- Target Recruit Count
- 31
- Registration Number
- NCT06399068
- Locations
- π°π·
Bumin Hospital, Seoul, Korea, Republic of
Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-387 in Healthy Volunteers Under Fasting Conditions
Phase 1
Completed
- Conditions
- Endocrine, Nutritional and Metabolic Diseases
- Interventions
- Drug: D484
- First Posted Date
- 2024-05-03
- Last Posted Date
- 2024-05-03
- Lead Sponsor
- Chong Kun Dang Pharmaceutical
- Target Recruit Count
- 37
- Registration Number
- NCT06399055
- Locations
- π°π·
Bumin Hospital, Seoul, Korea, Republic of
Clinical Study to Evaluate Pharmacokinetic Profiles and Safety of CKD-387 Under Fasting Condition
Phase 1
Completed
- Conditions
- Endocrine, Nutritional and Metabolic Diseases
- Interventions
- Drug: D484
- First Posted Date
- 2023-01-06
- Last Posted Date
- 2024-05-03
- Lead Sponsor
- Chong Kun Dang Pharmaceutical
- Target Recruit Count
- 40
- Registration Number
- NCT05673369
- Locations
- π°π·
Bumin Hospital, Seoul, Korea, Republic of
Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D635 Under Fed Condition
- First Posted Date
- 2019-02-21
- Last Posted Date
- 2019-02-21
- Lead Sponsor
- Chong Kun Dang Pharmaceutical
- Target Recruit Count
- 20
- Registration Number
- NCT03849339
- Locations
- π°π·
Severance Hospital, Seoul, Korea, Republic of
Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D635 in Healthy Adults
- First Posted Date
- 2019-02-21
- Last Posted Date
- 2019-02-21
- Lead Sponsor
- Chong Kun Dang Pharmaceutical
- Target Recruit Count
- 36
- Registration Number
- NCT03849261
- Locations
- π°π·
Severance Hospital, Seoul, Korea, Republic of
The Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-387 Under Fed Condition
- First Posted Date
- 2018-11-13
- Last Posted Date
- 2019-02-21
- Lead Sponsor
- Chong Kun Dang Pharmaceutical
- Target Recruit Count
- 23
- Registration Number
- NCT03738449
- Locations
- π°π·
Severance Hospital, Seoul, Korea, Republic of
Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D484 in Healthy Adults
- First Posted Date
- 2018-08-24
- Last Posted Date
- 2018-08-24
- Lead Sponsor
- Chong Kun Dang Pharmaceutical
- Target Recruit Count
- 36
- Registration Number
- NCT03646799
- Locations
- π°π·
Yonsei University Severance Hospital, Soeul, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
Β© Copyright 2025. All Rights Reserved by MedPath